Literature DB >> 3292672

Studies of surface immunoglobulin-dependent B cell activation.

J G Monroe1, V L Seyfert.   

Abstract

Studies from a number of laboratories have firmly established the potential of surface immunoglobulin-generated signals in B lymphocyte activation. While clearly there are multiple ways of activating B lymphocytes, some of which may not involve surface immunoglobulin, it is clear that crosslinking of surface immunoglobulin whether by antigen or antireceptor antibody can generate signals relevant to B cell activation. Although considerable insight into the mechanism of transduction of mIg-generated signals across the plasma membrane has been realized, a molecular explanation for linking inositol phospholipid hydrolysis to changes within the cytoplasm and nucleus of the B cell is still speculative. A more rigorous definition of the PKC and calcium components of the mIg signal transduction pathway are critical for a thorough understanding of the mechanism of signal transduction by this receptor. The use of tumor cell models allowing selection of mutants within the signalling pathway(s) will be invaluable to fully defining the critical molecular and biochemical events involved in B cell activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292672     DOI: 10.1007/bf02918097

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  103 in total

1.  Expression and function of I region products on immunocompetent cells. II. I region products in T-B interaction.

Authors:  C Henry; E L Chan; D Kodlin
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

2.  Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation.

Authors:  J Campisi; H E Gray; A B Pardee; M Dean; G E Sonenshein
Journal:  Cell       Date:  1984-02       Impact factor: 41.582

Review 3.  Use of the T lymphocyte regulated type 2 antigens for the analysis of responsiveness of Lyb5+ and Lyb5- B lymphocytes to T lymphocyte derived factors.

Authors:  J J Mond
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

4.  Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes.

Authors:  Z Z Chen; K M Coggeshall; J C Cambier
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

5.  A phosphatidylinositol kinase in rat mast cell granules.

Authors:  M Kurosawa; C W Parker
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

6.  Receptor-mediated inhibition of adenylate cyclase and stimulation of arachidonic acid release in 3T3 fibroblasts. Selective susceptibility to islet-activating protein, pertussis toxin.

Authors:  T Murayama; M Ui
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

7.  Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover.

Authors:  A Kishimoto; Y Takai; T Mori; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

8.  Role of the major histocompatibility complex in T cell activation of B cell subpopulations Lyb-5+ and Lyb-5- B cell subpopulations differ in their requirement for major histocompatibility complex-restricted T cell recognition.

Authors:  A Singer; P J Morrissey; K S Hathcock; A Ahmed; I Scher; R J Hodes
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

9.  Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes.

Authors:  T Pozzan; P Arslan; R Y Tsien; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

10.  Frequency of B lymphocytes responsive to anti-immunoglobulin.

Authors:  A L Defranco; E S Raveche; R Asofsky; W E Paul
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Use of isolated immature-stage B cells to understand negative selection and tolerance induction at the molecular level.

Authors:  A Norvell; M L Birkeland; J Carman; A L Sillman; R Wechsler-Reva; J G Monroe
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

2.  Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells.

Authors:  M Wu; M Arsura; R E Bellas; M J FitzGerald; H Lee; S L Schauer; D H Sherr; G E Sonenshein
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.

Authors:  M Wu; H Lee; R E Bellas; S L Schauer; M Arsura; D Katz; M J FitzGerald; T L Rothstein; D H Sherr; G E Sonenshein
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

4.  Developmentally regulated association of a 56-kD member of the surface immunoglobulin M receptor complex.

Authors:  A J Yellen-Shaw; J G Monroe
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

5.  Roles of the tumor suppressor p53 and the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in receptor-mediated apoptosis of WEHI 231 B lymphoma cells.

Authors:  M Wu; R E Bellas; J Shen; G E Sonenshein
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

6.  Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.

Authors:  H Lee; M Arsura; M Wu; M Duyao; A J Buckler; G E Sonenshein
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.